Oncologix Tech, Inc. announced a private placement of a promissory note for gross proceeds of $100,000 with a non-affiliated accredited Investor on July 26, 2013. The company issued an additional 2,500 series D convertible preferred stock in the transaction. The note carries a coupon of 18% per annum and would mature on January 26, 2015.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -50.00% | -50.00% | -96.00% |
2022 | DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction. | CI |
2016 | Oncologix Tech, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-96.00% | 166K | |
+128.17% | 7.23B | |
+2.57% | 984M | |
+41.91% | 883M | |
+16.11% | 764M | |
+2.11% | 667M | |
+1.44% | 642M | |
-.--% | 600M | |
+8.61% | 536M | |
-.--% | 500M |
- Stock Market
- Equities
- OCLG Stock
- News Oncologix Tech, Inc.
- Oncologix Tech, Inc. announced that it has received $0.1 million in funding